EPA Proposes Rollback of Ethylene Oxide Emission Limits, Reversing Biden-Era Cancer Risk Findings
Washington D.C. – In a move that reverses recent efforts to curb exposure to a known carcinogen, the U.S. Environmental Protection Agency (EPA) has proposed weakening air pollution limits on ethylene oxide (EtO), a chemical widely used to sterilize medical equipment. The proposed rule, announced on Friday, March 14, 2026, would effectively roll back stricter standards established by the Biden administration, which aimed to reduce cancer risks for communities near commercial sterilization facilities. The EPA stated its concern that the current standards “actively threaten” manufacturers’ ability to sterilize equipment and “jeopardize one of America’s only options for a secure domestic supply chain of essential medical equipment.”
Ethylene oxide is a colorless gas crucial for sterilizing approximately half of all medical devices in the United States, including catheters, syringes, pacemakers, and plastic surgical gowns. While essential for ensuring the safety of these life-saving tools, long-term exposure to EtO has been definitively linked to an increased risk of leukemia, breast cancer, and lymphoma, according to the EPA’s own classification in 2016. The proposed rollback has sparked immediate criticism from public health advocates and environmental justice groups, who argue that it prioritizes industry interests over the health and safety of vulnerable communities.
The decision marks the latest in a series of actions under the Trump administration to relax environmental regulations and reduce costs for industry. In February 2025 alone, the agency weakened restrictions on mercury emissions from coal-burning power plants and repealed a scientific finding that underpinned U.S. Action to regulate greenhouse gas emissions. This pattern has raised concerns about a broader shift away from environmental protection and a weakening of safeguards designed to protect public health.
Biden-Era Rule Aimed for 90% Emission Reduction
The current regulations, finalized in 2024, were designed to reduce ethylene oxide emissions by approximately 90% across nearly 90 commercial sterilization facilities nationwide. The rule mandated that companies test for EtO in the surrounding air and ensure their pollution control technologies were functioning effectively. This followed a 2022 EPA assessment that detailed the risks faced by residents living near these facilities, including a specific case in Laredo, Texas, where activists fought for cleanup of a sterilization plant operated by Midwest Sterilization Corp. The EPA identified 23 sterilizers across the U.S. Posing a significant risk to nearby populations.
The proposed rollback has drawn swift condemnation from organizations dedicated to public health. Laura Kate Bender, vice president of the American Lung Association, called the proposed rule change “unacceptable,” stating, “The science shows that both short-term and long-term exposure to ethylene oxide is dangerous for health. People who live near many commercial sterilization facilities are much more likely to develop cancer over their lifetimes. No one should have to live with elevated cancer risk because of air pollution in their community.”
Environmental Justice Concerns Highlight Disproportionate Impact
Advocates for environmental justice have emphasized that many EtO sterilization facilities are located in minority communities, exposing Black and Brown populations to disproportionately high levels of the carcinogenic chemical. This raises concerns about systemic environmental racism and the need for equitable protection from pollution. The rollback, critics argue, would exacerbate these existing inequalities and further endanger already vulnerable communities.
The Advanced Medical Technology Association (AdMedTechA), representing medical sterilizers, expressed appreciation for the EPA’s consideration of the industry’s concerns. Scott Whitaker, president and CEO of AdMedTechA, stated, “We appreciate the EPA’s efforts in listening to and understanding the importance of supplying safe, sterile medical technology without interruption while protecting employees and communities near sterilization facilities.” This suggests a tension between the need to ensure a reliable supply of sterilized medical devices and the imperative to protect public health from the harmful effects of EtO exposure.
Sterigenics Case and Legal Battles
The issue of EtO emissions has been the subject of legal battles in recent years. Sterigenics, a major sterilization company, was forced to shutter a plant in a Chicago suburb after monitoring revealed elevated emissions in nearby neighborhoods. The company subsequently settled numerous lawsuits brought by residents alleging health problems linked to EtO exposure. This case highlighted the potential for significant health impacts from EtO emissions and the legal liabilities faced by sterilization facilities.
The EPA’s decision to propose weaker pollution limits comes as the agency faces pressure from both industry groups concerned about the cost of compliance and public health advocates demanding stronger protections. The proposed rule is now subject to public comment and review, and its final form could be significantly altered before it is implemented. The agency has not yet specified a timeline for finalizing the rule.
What is Ethylene Oxide and Why is it Used?
Ethylene oxide, also known as EtO, is a highly reactive chemical compound primarily used for sterilization. It’s a gas at room temperature and is incredibly effective at killing bacteria, viruses, and other microorganisms that can contaminate medical devices. Approximately half of all medical devices are sterilized using EtO, making it a critical component of modern healthcare. Beyond medical applications, EtO is also used to sterilize spices, dried herbs, and other food products, ensuring their safety for consumption. But, the very properties that craft EtO an effective sterilant – its high reactivity – also contribute to its carcinogenic potential.
Looking Ahead: Public Comment and Potential Legal Challenges
The EPA’s proposed rule is now open for public comment, providing an opportunity for stakeholders to voice their concerns and provide input on the agency’s decision. It is anticipated that the proposal will face significant opposition from environmental and public health groups, potentially leading to legal challenges. The outcome of this process will have significant implications for the regulation of EtO emissions and the protection of communities living near sterilization facilities. The EPA has not yet announced a deadline for the public comment period, but it is expected to be several weeks long. Following the comment period, the agency will review the submissions and determine whether to proceed with the proposed rule, modify it, or withdraw it altogether.
The debate over ethylene oxide emissions underscores the complex challenges of balancing public health concerns with the need to ensure a reliable supply of essential medical devices. As the EPA moves forward with its review of the proposed rule, it will be crucial to consider the scientific evidence, the concerns of affected communities, and the potential impacts on both the healthcare industry and the environment.
The next step in this process will be the publication of the proposed rule in the Federal Register, which will formally initiate the public comment period. Readers are encouraged to submit their comments to the EPA and to stay informed about this important issue. Further updates will be provided as they become available.
Keep reading